These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 18842704

  • 1. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
    Ko MC, Husbands SM.
    J Pharmacol Exp Ther; 2009 Jan; 328(1):193-200. PubMed ID: 18842704
    [Abstract] [Full Text] [Related]

  • 2. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice.
    Sakakihara M, Imamachi N, Saito Y.
    Reg Anesth Pain Med; 2016 Jan; 41(1):69-74. PubMed ID: 26587674
    [Abstract] [Full Text] [Related]

  • 3. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
    Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, Naughton NN.
    J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
    [Abstract] [Full Text] [Related]

  • 4. Effects of butorphanol on morphine-induced itch and analgesia in primates.
    Lee H, Naughton NN, Woods JH, Ko MC.
    Anesthesiology; 2007 Sep; 107(3):478-85. PubMed ID: 17721251
    [Abstract] [Full Text] [Related]

  • 5. Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice.
    Takasaki I, Suzuki T, Sasaki A, Nakao K, Hirakata M, Okano K, Tanaka T, Nagase H, Shiraki K, Nojima H, Kuraishi Y.
    J Pharmacol Exp Ther; 2004 Apr; 309(1):36-41. PubMed ID: 14711930
    [Abstract] [Full Text] [Related]

  • 6. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.
    Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH.
    Brain Res; 2003 Aug 22; 982(1):38-44. PubMed ID: 12915238
    [Abstract] [Full Text] [Related]

  • 7. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys.
    Endoh T, Tajima A, Izumimoto N, Suzuki T, Saitoh A, Suzuki T, Narita M, Kamei J, Tseng LF, Mizoguchi H, Nagase H.
    Jpn J Pharmacol; 2001 Mar 22; 85(3):282-90. PubMed ID: 11325021
    [Abstract] [Full Text] [Related]

  • 8. Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
    Huskinson SL, Platt DM, Brasfield M, Follett ME, Prisinzano TE, Blough BE, Freeman KB.
    Psychopharmacology (Berl); 2020 Jul 22; 237(7):2075-2087. PubMed ID: 32372348
    [Abstract] [Full Text] [Related]

  • 9. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y, Tang K, Inan S, Siebert D, Holzgrabe U, Lee DY, Huang P, Li JG, Cowan A, Liu-Chen LY.
    J Pharmacol Exp Ther; 2005 Jan 22; 312(1):220-30. PubMed ID: 15383632
    [Abstract] [Full Text] [Related]

  • 10. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.
    Kaski SW, White AN, Gross JD, Trexler KR, Wix K, Harland AA, Prisinzano TE, Aubé J, Kinsey SG, Kenakin T, Siderovski DP, Setola V.
    J Pharmacol Exp Ther; 2019 Nov 22; 371(2):487-499. PubMed ID: 31492823
    [Abstract] [Full Text] [Related]

  • 11. Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.
    Lazenka ML, Moerke MJ, Townsend EA, Freeman KB, Carroll FI, Negus SS.
    Psychopharmacology (Berl); 2018 Jan 22; 235(1):203-213. PubMed ID: 29063139
    [Abstract] [Full Text] [Related]

  • 12. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.
    Umeuchi H, Togashi Y, Honda T, Nakao K, Okano K, Tanaka T, Nagase H.
    Eur J Pharmacol; 2003 Sep 05; 477(1):29-35. PubMed ID: 14512095
    [Abstract] [Full Text] [Related]

  • 13. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
    Tsuji M, Yamazaki M, Takeda H, Matsumiya T, Nagase H, Tseng LF, Narita M, Suzuki T.
    Eur J Pharmacol; 2000 Apr 07; 394(1):91-5. PubMed ID: 10771039
    [Abstract] [Full Text] [Related]

  • 14. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
    Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, Negus SS.
    J Pharmacol Exp Ther; 2003 Dec 07; 307(3):1054-64. PubMed ID: 14557380
    [Abstract] [Full Text] [Related]

  • 15. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
    Schattauer SS, Kuhar JR, Song A, Chavkin C.
    Cell Signal; 2017 Apr 07; 32():59-65. PubMed ID: 28088389
    [Abstract] [Full Text] [Related]

  • 16. The role of central mu opioid receptors in opioid-induced itch in primates.
    Ko MC, Song MS, Edwards T, Lee H, Naughton NN.
    J Pharmacol Exp Ther; 2004 Jul 07; 310(1):169-76. PubMed ID: 15044556
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys.
    Wakasa Y, Fujiwara A, Umeuchi H, Endoh T, Okano K, Tanaka T, Nagase H.
    Life Sci; 2004 Oct 29; 75(24):2947-57. PubMed ID: 15454345
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the antinociceptive effects of TRK-820 in the rat.
    Endoh T, Tajima A, Suzuki T, Kamei J, Narita M, Tseng L, Nagase H.
    Eur J Pharmacol; 2000 Jan 10; 387(2):133-40. PubMed ID: 10650153
    [Abstract] [Full Text] [Related]

  • 19. Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice.
    Dunn A, Windisch K, Ben-Ezra A, Pikus P, Morochnik M, Erazo J, Reed B, Kreek MJ.
    Psychopharmacology (Berl); 2020 Aug 10; 237(8):2405-2418. PubMed ID: 32435819
    [Abstract] [Full Text] [Related]

  • 20. Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
    Liu JJ, Chiu YT, DiMattio KM, Chen C, Huang P, Gentile TA, Muschamp JW, Cowan A, Mann M, Liu-Chen LY.
    Neuropsychopharmacology; 2019 Apr 10; 44(5):939-949. PubMed ID: 30082888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.